Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cytokinetics Inc (NASDAQ:CYTK)

Delayed Data
As of Oct 05
 +0.09 / +1.29%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Cytokinetics Inc have a median target of 14.00, with a high estimate of 18.00 and a low estimate of 9.00. The median estimate represents a +98.58% increase from the last price of 7.05.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in Cytokinetics Inc. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Oct 29

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -11.11%
Growthannually -175.61%


Growthquarterly 58.76%
Growthannually -27.94%
Key to the earnings and sales forecast charts.